Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses

OBJECTIVE: Generalized myasthenia gravis (gMG) is an autoimmune disease that causes disabling weakness via damage to the neuromuscular junction. In most patients, the disease is mediated by autoantibodies to the acetylcholine receptor, which activate the complement cascade. Our objective was to anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, James F., Karam, Chafic, Yountz, Marcus, O’Brien, Fanny L., Mozaffar, Tahseen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283175/
https://www.ncbi.nlm.nih.gov/pubmed/34043280
http://dx.doi.org/10.1002/acn3.51376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283175/
https://www.ncbi.nlm.nih.gov/pubmed/34043280
http://dx.doi.org/10.1002/acn3.51376

Ejemplares similares